Bachem Investor Relations Material
Latest events
H1 2025
Bachem
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Bachem Holding AG
Access all reports
Bachem Holding AG develops and manufactures peptides and oligonucleotides for the pharmaceutical and biotechnology industries. The company offers products and services for research, clinical development, and commercial-scale production of active pharmaceutical ingredients. It supports customers with custom synthesis and contract manufacturing. The company is headquartered in Bubendorf, Switzerland, and its shares are listed on the SIX.
Key slides for Bachem Holding AG
CMD 2024
Bachem Holding AG
H2 2024
Bachem Holding AG
Latest articles
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
)
Global Doughmination: Breaking Down Domino's Pizza
Inside the rise of Domino's Pizza: how franchising, delivery control, and supply chain mastery built one of the world's most efficient food empires.
18 Jul 2025
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
Ticker symbol
BANB
Country
🇨🇭 Switzerland